Answers are grounded in this paper and cite their sources.
Treatment of extensively drug-resistant tuberculosis (XDR-TB) is a challenge. We describe a young child with pulmonary XDR-TB who did not respond to an aggressive multidrug-resistant TB treatment regimen, but was cured with linezolid in combination with other reserve antituberculous drugs. No serious adverse events were observed during 19 months of treatment for XDR-TB.
No takes yet. Share an insight, caveat, or question.
Schaaf et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: